1 Reason I Wouldn’t Buy Barclays PLC Today

Royston Wild explains why Barclays PLC (LON: BARC) is set for further legal problems.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I am looking at why Barclays (LSE: BARC) (NYSE: BCS.US) could be considered a risky share selection.

Courtroom chaos rolls on and on

Unfortunately for Barclays, there appears to be no end to the steady stream of misconduct allegations stretching back to before the 2008/2009 banking crisis, a situation that could cause a significant drain on the balance sheet as the prospect of severe financial penalties drags on.

Most notably Barclays is currently locked in controversy over its ‘dark pool’ private trading platform, with the New York attorney general asserting that the bank had “demonstrated a disturbing disregard for its investors in a systematic pattern of fraud and deceit” to benefit its high-frequency traders.

In an unusual step Barclays has elected to vigorously fight the case in court rather than negotiate a settlement with regulators. But the Barclaysconsequences of the case could result in catastrophic fines for the bank if found guilty, not to mention the wider effect of Barclays’ being dragged through the mud once again — volumes at the firm’s trading platform have already fallen through the floor since the claims emerged.

And the firm’s legal team received a further blow to the solar plexus this week when it, along with more than a dozen other banks including HSBC and Royal Bank of Scotland, was hit with a $1.15bn lawsuit from the US State of Virginia. The plaintiff claims that the banks defrauded the state’s retirement fund by selling it sub-standard mortgage bonds between 2004 and 2010.

Barclays, like the majority of the UK’s biggest banking players, has also had to set aside vast sums to cover a vast array of misdeeds. The mis-selling of payment protection insurance (PPI) has been one of the biggest headaches for the bank, and Barclays added a further £900m for redress during January-June.

Figures released last month suggested that the company could be turning the corner on this front, however, with new general insurance and PPI complaints toppling by 37% to 182,564 during the first half. But since then the Financial Conduct Authority (FCA) ordered 2.5 million cases assessed between 2012 and 2013, where claims may have been wrongly rejected or claimants undercompensated, to be reappraised.

By the looks of things Barclays looks set to remain locked in costly litigation battles for some time to come, making a final bill nigh-on impossible to predict but which could have a hugely-detrimental effect on earnings.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

This 1 simple investing move accelerated Warren Buffett’s wealth creation

Warren Buffett has used this easy to understand investing technique for decades -- and it has made him billions. Our…

Read more »

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

Down 6% in 2 weeks, the Lloyds share price is in reverse

After hitting a one-year high on 8 April, the Lloyds share price has suddenly reversed course. But as a long-term…

Read more »

Investing Articles

£3,000 in savings? Here’s how I’d use that to start earning a monthly passive income

Our writer digs into the details of how spending a few thousand pounds on dividend shares now could help him…

Read more »

Investing Articles

Here’s what dividend forecasts could do for the BP share price in the next three years

I can understand why the BP share price is low, as oil's increasingly seen as evil. But BP's a cash…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

This FTSE 100 Dividend Aristocrat is on sale now

Stephen Wright thinks Croda International’s impressive dividend record means it could be the best FTSE 100 stock to add to…

Read more »

Investing Articles

3 shares I’d buy for passive income if I was retiring early

Roland Head profiles three FTSE 350 dividend shares he’d like to buy for their passive income to support an early…

Read more »

Investing Articles

Here’s how many Aviva shares I’d need for £1,000 a year in passive income

Our writer has been buying shares of this FTSE 100 insurer, but how many would he need to aim for…

Read more »

Female Doctor In White Coat Having Meeting With Woman Patient In Office
Investing Articles

1 incredible growth stock I can’t find on the FTSE 100

The FTSE 100 offers us a lot of interesting investment opportunities, but there's not much in the way of traditional…

Read more »